These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15592473)

  • 21. Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.
    Santiago-Raber ML; Amano H; Amano E; Baudino L; Otani M; Lin Q; Nimmerjahn F; Verbeek JS; Ravetch JV; Takasaki Y; Hirose S; Izui S
    Arthritis Rheum; 2009 Aug; 60(8):2408-17. PubMed ID: 19644866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of autoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus.
    Ma Z; Chen F; Madaio MP; Cohen PL; Eisenberg RA
    J Immunol; 2006 Nov; 177(10):7444-50. PubMed ID: 17082664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.
    Tiller T; Kofer J; Kreschel C; Busse CE; Riebel S; Wickert S; Oden F; Mertes MM; Ehlers M; Wardemann H
    J Exp Med; 2010 Nov; 207(12):2767-78. PubMed ID: 21078890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of tolerance in lupus by targeted inhibitory receptor expression.
    McGaha TL; Sorrentino B; Ravetch JV
    Science; 2005 Jan; 307(5709):590-3. PubMed ID: 15681388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic dissection of the effects of stimulatory and inhibitory IgG Fc receptors on murine lupus.
    Lin Q; Xiu Y; Jiang Y; Tsurui H; Nakamura K; Kodera S; Ohtsuji M; Ohtsuji N; Shiroiwa W; Tsukamoto K; Amano H; Amano E; Kinoshita K; Sudo K; Nishimura H; Izui S; Shirai T; Hirose S
    J Immunol; 2006 Aug; 177(3):1646-54. PubMed ID: 16849473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells.
    Liu Y; Li L; Kumar KR; Xie C; Lightfoot S; Zhou XJ; Kearney JF; Weigert M; Mohan C
    J Immunol; 2007 Jul; 179(2):1340-52. PubMed ID: 17617627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic design and testing of nested (RT-)PCR primers for specific amplification of mouse rearranged/expressed immunoglobulin variable region genes from small number of B cells.
    Rohatgi S; Ganju P; Sehgal D
    J Immunol Methods; 2008 Dec; 339(2):205-19. PubMed ID: 18926828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice.
    Yarkoni Y; Fischel R; Kat I; Yachimovich-Cohen N; Eilat D
    Eur J Immunol; 2006 Oct; 36(10):2755-67. PubMed ID: 16983722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of activating and inhibiting Fc-receptors on murine mercury-induced autoimmunity.
    Martinsson K; Carlsson L; Kleinau S; Hultman P
    J Autoimmun; 2008 Aug; 31(1):22-9. PubMed ID: 18314309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The skewed heavy-chain repertoire in peritoneal B-1 cells is predetermined by the selection via pre-B cell receptor during B cell ontogeny in the fetal liver.
    Yoshikawa S; Kawano Y; Minegishi Y; Karasuyama H
    Int Immunol; 2009 Jan; 21(1):43-52. PubMed ID: 19011159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.
    Lei TC; Su Y; Scott DW
    Cell Immunol; 2005 May; 235(1):12-20. PubMed ID: 16098495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion.
    Doyle CM; Han J; Weigert MG; Prak ET
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11264-9. PubMed ID: 16847259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.